BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30257642)

  • 21. Elevation of the Plasma Aβ40/Aβ42 Ratio as a Diagnostic Marker of Sporadic Early-Onset Alzheimer's Disease.
    Kim HJ; Park KW; Kim TE; Im JY; Shin HS; Kim S; Lee DH; Ye BS; Kim JH; Kim EJ; Park KH; Han HJ; Jeong JH; Choi SH; Park SA
    J Alzheimers Dis; 2015; 48(4):1043-50. PubMed ID: 26444752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of plasma biomarkers and clinical data for the detection of sporadic Alzheimer's disease.
    Han Y; Jia J; Jia XF; Qin W; Wang S
    Neurosci Lett; 2012 May; 516(2):232-6. PubMed ID: 22503901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid-β 42/40 cerebrospinal fluid concentration ratio in the diagnostics of Alzheimer's disease: validation of two novel assays.
    Lewczuk P; Lelental N; Spitzer P; Maler JM; Kornhuber J
    J Alzheimers Dis; 2015; 43(1):183-91. PubMed ID: 25079805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clusterin Levels in Plasma Predict Cognitive Decline and Progression to Alzheimer's Disease.
    Jongbloed W; van Dijk KD; Mulder SD; van de Berg WD; Blankenstein MA; van der Flier W; Veerhuis R
    J Alzheimers Dis; 2015; 46(4):1103-10. PubMed ID: 26402636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salivary biomarkers in Alzheimer's disease.
    Tvarijonaviciute A; Zamora C; Ceron JJ; Bravo-Cantero AF; Pardo-Marin L; Valverde S; Lopez-Jornet P
    Clin Oral Investig; 2020 Oct; 24(10):3437-3444. PubMed ID: 31989369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer's disease study.
    Jongbloed W; Kester MI; van der Flier WM; Veerhuis R; Scheltens P; Blankenstein MA; Teunissen CE
    Alzheimers Dement; 2013 May; 9(3):276-83. PubMed ID: 23110867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies.
    Mulugeta E; Londos E; Ballard C; Alves G; Zetterberg H; Blennow K; Skogseth R; Minthon L; Aarsland D
    J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):160-4. PubMed ID: 21047883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Associations between a Capsaicin-Rich Diet and Blood Amyloid-β Levels and Cognitive Function.
    Liu CH; Bu XL; Wang J; Zhang T; Xiang Y; Shen LL; Wang QH; Deng B; Wang X; Zhu C; Yao XQ; Zhang M; Zhou HD; Wang YJ
    J Alzheimers Dis; 2016 Apr; 52(3):1081-8. PubMed ID: 27079706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of Aβ Monomers and Oligomers: Early Diagnosis of Alzheimer's Disease.
    Zhou Y; Liu L; Hao Y; Xu M
    Chem Asian J; 2016 Mar; 11(6):805-17. PubMed ID: 26994700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression - inverse correlation with dementia severity.
    Hock C; Golombowski S; Müller-Spahn F; Naser W; Beyreuther K; Mönning U; Schenk D; Vigo-Pelfrey C; Bush AM; Moir R; Tanzi RE; Growdon JH; Nitsch RM
    Eur Neurol; 1998; 39(2):111-8. PubMed ID: 9520072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomarkers for Alzheimer's Disease in Saliva: A Systematic Review.
    Gleerup HS; Hasselbalch SG; Simonsen AH
    Dis Markers; 2019; 2019():4761054. PubMed ID: 31191751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of two analytical platforms for the clinical qualification of Alzheimer's disease biomarkers in pathologically-confirmed dementia.
    Le Bastard N; Coart E; Vanderstichele H; Vanmechelen E; Martin JJ; Engelborghs S
    J Alzheimers Dis; 2013; 33(1):117-31. PubMed ID: 22936010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.
    Shea YF; Ha J; Chu LW
    Psychogeriatrics; 2015 Dec; 15(4):235-41. PubMed ID: 25533477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Critical Comparison of Different Biomarkers for Alzheimer's Disease in a Clinical Setting.
    Weise D; Tiepolt S; Awissus C; Hoffmann KT; Lobsien D; Kaiser T; Barthel H; Sabri O; Gertz HJ
    J Alzheimers Dis; 2015; 48(2):425-32. PubMed ID: 26402006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer's Disease.
    Niemantsverdriet E; Goossens J; Struyfs H; Martin JJ; Goeman J; De Deyn PP; Vanderstichele H; Engelborghs S
    J Alzheimers Dis; 2016; 51(1):97-106. PubMed ID: 26836187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloid beta pathology in Alzheimer's disease and schizophrenia.
    Religa D; Laudon H; Styczynska M; Winblad B; Näslund J; Haroutunian V
    Am J Psychiatry; 2003 May; 160(5):867-72. PubMed ID: 12727689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson's Disease.
    Bach JP; Gold M; Mengel D; Hattesohl A; Lubbe D; Schmid S; Tackenberg B; Rieke J; Maddula S; Baumbach JI; Nell C; Boeselt T; Michelis J; Alferink J; Heneka M; Oertel W; Jessen F; Janciauskiene S; Vogelmeier C; Dodel R; Koczulla AR
    PLoS One; 2015; 10(7):e0132227. PubMed ID: 26168044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort.
    Seeburger JL; Holder DJ; Combrinck M; Joachim C; Laterza O; Tanen M; Dallob A; Chappell D; Snyder K; Flynn M; Simon A; Modur V; Potter WZ; Wilcock G; Savage MJ; Smith AD
    J Alzheimers Dis; 2015; 44(2):525-39. PubMed ID: 25391385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic Accuracy of Cerebrospinal Fluid Amyloid-β Isoforms for Early and Differential Dementia Diagnosis.
    Struyfs H; Van Broeck B; Timmers M; Fransen E; Sleegers K; Van Broeckhoven C; De Deyn PP; Streffer JR; Mercken M; Engelborghs S
    J Alzheimers Dis; 2015; 45(3):813-22. PubMed ID: 25633670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Search for biomarkers of Alzheimer's disease: Recent insights, current challenges and future prospects.
    Hrubešová K; Fousková M; Habartová L; Fišar Z; Jirák R; Raboch J; Setnička V
    Clin Biochem; 2019 Oct; 72():39-51. PubMed ID: 30953619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.